Next |
home / stock / aqxp / aqxp message board
Subject | By | Source | When |
---|---|---|---|
agreed! | wesley_ | investorshub | 08/08/2019 3:56:51 PM |
Very nice thin mover, not done imo | Klinsmann | investorshub | 08/08/2019 3:45:04 PM |
$3.56 on nice volume, loaded some | wesley_ | investorshub | 08/08/2019 3:00:07 PM |
Aweiner | investorshub | 05/02/2019 2:50:42 PM | |
20% up - not too shabby and on | Klinsmann | investorshub | 02/14/2019 5:44:13 PM |
Regarding the 5 year chart for $AQXP - | Klinsmann | investorshub | 12/01/2018 2:10:27 PM |
Looks like turning again, at least wont go | Klinsmann | investorshub | 11/23/2018 3:31:40 PM |
Looks like we will be going below 2 soon. | ZLAZARUS | investorshub | 11/14/2018 11:46:53 PM |
Looks like we will continue to hover around 2.50 | ZLAZARUS | investorshub | 11/03/2018 5:30:57 AM |
Very over sold, Very true.. Good luck to | ZLAZARUS | investorshub | 08/09/2018 6:54:26 PM |
That opportunity has passed. 10Q came out | Vector93 | investorshub | 08/09/2018 4:29:04 PM |
When do you expect this? | Brilliantlexx13 | investorshub | 08/08/2018 8:36:56 PM |
I got out at 3.18 ... looking to | ZLAZARUS | investorshub | 07/22/2018 5:22:41 PM |
we are very close to the party. | aristotelisonassis | investorshub | 07/19/2018 9:24:16 PM |
The show is about to start. | ZLAZARUS | investorshub | 07/19/2018 4:08:22 AM |
get ready ladies and gents. | aristotelisonassis | investorshub | 07/18/2018 7:43:21 PM |
* * $AQXP Video Chart 07-17-18 * * | ClayTrader | investorshub | 07/17/2018 9:10:08 PM |
I agree! | ZLAZARUS | investorshub | 07/17/2018 8:50:20 PM |
$AQXP holding overnight and for the next days. | aristotelisonassis | investorshub | 07/17/2018 8:08:29 PM |
she is ready for a huge squeeze. Get | aristotelisonassis | investorshub | 07/17/2018 7:40:27 PM |
News, Short Squeeze, Breakout and More Instantly...
Aquinox Pharmaceuticals Inc. Company Name:
AQXP Stock Symbol:
NASDAQ Market:
Aquinox Pharmaceuticals Inc. Website:
Nasdaq Ticker Symbol “NLTX” to be effective Monday, August 12, 2019 SEATTLE, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein...
SEATTLE, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. (“Neoleukin”), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, and Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP),...
• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/IL-15 agonist with favorable t...